Home / Products / Cancer (Tumor) Cell Lines / OE19
OE19
Datasheet Protocol

OE19

Cat. No. ARC0692
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Esophagus

Growth Properties:

Adherent

In stock
$1,500.00 / Vial
Ask a Question

Short Description 🔒

OE19 is a cancer cell line of esophagus adenocarcinoma, isolated from in situ; esophagus.
 
Synonym: OE-19; JROECL 19; JROECL19; OEC19

Recommended Products

LACTB2 Knockout jurkat Polyclonal Cells LACTB2 Knockout jurkat Polyclonal Cells Cat. No. ARG13192 ABL2 Knockout HT29 Polyclonal Cells ABL2 Knockout HT29 Polyclonal Cells Cat. No. ARG32813 BRSK2 Knockout Hela Polyclonal Cells BRSK2 Knockout Hela Polyclonal Cells Cat. No. ARG37266 DNAJC10 Knockout MES-OV Polyclonal Cells DNAJC10 Knockout MES-OV Polyclonal Cells Cat. No. ARG39187 ATAD1 Knockout AGS Polyclonal Cells ATAD1 Knockout AGS Polyclonal Cells Cat. No. ARG26674 LONP2 Knockout Raji Polyclonal Cells LONP2 Knockout Raji Polyclonal Cells Cat. No. ARG1817
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Esophagus
Disease:
Adenocarcinoma
Morphology:
Epithelial-like
Growth Mode:
Adherent
Age:
72 years
Sex of Donor:
Male
Derived From Site:
In situ; Esophagus
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

CWC15 Knockout Hela Polyclonal Cells

CWC15 Knockout Hela Polyclonal Cells

Cat. No. ARG8294
 ANKRD53 Knockout HAP1 Polyclonal Cells

ANKRD53 Knockout HAP1 Polyclonal Cells

Cat. No. ARG21824
 ABL2 Knockout MES-OV Polyclonal Cells

ABL2 Knockout MES-OV Polyclonal Cells

Cat. No. ARG24006
 ARHGDIA Knockout A549 Polyclonal Cells

ARHGDIA Knockout A549 Polyclonal Cells

Cat. No. ARG34524
 NEFH Knockout CaSki Polyclonal Cells

NEFH Knockout CaSki Polyclonal Cells

Cat. No. ARG9893
 CSRP3 Knockout Raji Polyclonal Cells

CSRP3 Knockout Raji Polyclonal Cells

Cat. No. ARG1555